# The Efficacy of APT Magnetic Resonance Imaging in Predicting the Efficacy of Bevacizumab in Recurrent Malignant Gliomas

> **NCT03180697** · — · UNKNOWN · sponsor: **Zhujiang Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Diagnoses Disease
- Glioma of Brain

## Interventions

- **DIAGNOSTIC_TEST:** APT MR Imaging

## Key facts

- **NCT ID:** NCT03180697
- **Lead sponsor:** Zhujiang Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-06-03
- **Primary completion:** 2021-09-30
- **Final completion:** 2021-10-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2017-06-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03180697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03180697, "The Efficacy of APT Magnetic Resonance Imaging in Predicting the Efficacy of Bevacizumab in Recurrent Malignant Gliomas". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03180697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*